Chardan Capital Has Negative Outlook of FBRX FY2025 Earnings
Forte Biosciences, Inc. (NASDAQ:FBRX – Free Report) – Equities research analysts at Chardan Capital cut their FY2025 earnings per share estimates for Forte Biosciences in a research report issued to clients and investors on Wednesday, April 2nd. Chardan Capital analyst D. Gataulin now expects that the company will post earnings of ($4.25) per share for […]
Forte Biosciences, Inc. (NASDAQ:FBRX – Free Report) – Equities research analysts at Chardan Capital cut their FY2025 earnings per share estimates for Forte Biosciences in a research report issued to clients and investors on Wednesday, April 2nd. Chardan Capital analyst D. Gataulin now expects that the company will post earnings of ($4.25) per share for […]
